Breaking News Instant updates and real-time market news.

HLT

Hilton

$125.24 /

+2.105 (+1.71%)

, HST

Host Hotels

$15.77 /

-0.14 (-0.88%)

08:20
07/24/21
07/24
08:20
07/24/21
08:20

Rising COVID cases hang heavy over travel industry, Barron's says

While the Delta variant has been spreading for months, the highly contagious COVID-19 variant seized headlines over the past week or so as cases and deaths climbed - particularly among the unvaccinated - and concerns grew that governments might reimpose restrictions on crowds and business operations, Lawrence Strauss writes in this week's edition of Barron's. The travel and leisure industries have been beset by crosscurrents, but Hilton (HLT), Host Hotels & Resorts (HST), MGM Growth Properties (MGP), Royal Caribbean (RCL), Travel + Leisure (TNL), and Wyndham Hotels & Resorts (WH) have some attributes to withstand uncertain stretches, the author notes. Reference Link

HLT

Hilton

$125.24 /

+2.105 (+1.71%)

HST

Host Hotels

$15.77 /

-0.14 (-0.88%)

MGP

MGM Growth

$37.78 /

+0.33 (+0.88%)

RCL

Royal Caribbean

$77.70 /

-0.06 (-0.08%)

TNL

Travel + Leisure

$56.48 /

-0.52 (-0.91%)

WH

Wyndham Hotels & Resorts

$69.78 /

+0.28 (+0.40%)

  • 28

    Jul

  • 29

    Jul

  • 29

    Jul

  • 04

    Aug

  • 06

    Aug

  • 14

    Oct

  • 01

    Mar

  • 11

    Mar

HLT Hilton
$125.24 /

+2.105 (+1.71%)

05/06/21 Raymond James
Hilton price target raised to $135 from $125 at Raymond James
05/06/21 Deutsche Bank
Hilton price target raised to $113 from $104 at Deutsche Bank
04/20/21 Truist
Hilton price target raised to $114 from $106 at Truist
03/22/21 Baird
Hilton price target raised to $128 from $126 at Baird
HST Host Hotels
$15.77 /

-0.14 (-0.88%)

06/18/21 Capital One
Capital One upgraded Host Hotels with 'more pros than cons'
06/17/21 Capital One
Host Hotels upgraded to Overweight from Equalweight at Capital One
05/14/21 Evercore ISI
Host Hotels upgraded to Outperform from In Line at Evercore ISI
04/12/21 Baird
Host Hotels talks for Four Seasons Orlando 'moving along,' says Baird
MGP MGM Growth
$37.78 /

+0.33 (+0.88%)

06/14/21 Wolfe Research
MGM Growth initiated with a Peer Perform at Wolfe Research
05/04/21 Morgan Stanley
MGM Growth price target raised to $38 from $34 at Morgan Stanley
05/04/21 BofA
MGM Growth double-downgraded to Underperform from Buy at BofA
05/03/21 Deutsche Bank
MGM Growth price target raised to $40 from $38 at Deutsche Bank
RCL Royal Caribbean
$77.70 /

-0.06 (-0.08%)

06/29/21 Stifel
Royal Caribbean selloff creates 'solid buying opportunity,' says Stifel
06/17/21 JPMorgan
Royal Caribbean price target raised to $123 from $112 at JPMorgan
06/16/21 Wolfe Research
Wolfe upgrades 'Big 3' cruise stocks on improving booking momentum
06/16/21 Wolfe Research
Royal Caribbean upgraded to Outperform from Peer Perform at Wolfe Research
TNL Travel + Leisure
$56.48 /

-0.52 (-0.91%)

04/29/21 Credit Suisse
Travel + Leisure price target raised to $81 from $76 at Credit Suisse
04/29/21 Deutsche Bank
Travel + Leisure price target raised to $78 from $69 at Deutsche Bank
03/15/21 JPMorgan
Travel + Leisure price target raised to $71 from $66 at JPMorgan
03/05/21 Truist
Travel + Leisure price target raised to $74 from $62 at Truist
WH Wyndham Hotels & Resorts
$69.78 /

+0.28 (+0.40%)

04/30/21 Truist
Wyndham Hotels & Resorts price target raised to $81 from $68 at Truist
04/30/21 Jefferies
Wyndham Hotels & Resorts price target raised to $91 from $85 at Jefferies
04/29/21 Oppenheimer
Wyndham Hotels & Resorts price target raised to $80 from $70 at Oppenheimer
04/21/21 JPMorgan
Wyndham Hotels & Resorts price target raised to $74 from $67 at JPMorgan

TODAY'S FREE FLY STORIES

Downgrade
Maersk Drilling downgraded to Hold from Buy at Pareto » 05:27
10/20/21
10/20
05:27
10/20/21
05:27
DDRLF

Maersk Drilling

$38.92 /

+ (+0.00%)

Pareto analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDRLF Maersk Drilling
$38.92 /

+ (+0.00%)

10/15/21 JPMorgan
Maersk Drilling price target raised to DKK 285 from DKK 284 at JPMorgan
10/15/21 SEB Equities
Maersk Drilling upgraded to Buy from Hold at SEB Equities
08/23/21 Kepler Cheuvreux
Maersk Drilling upgraded to Hold from Reduce at Kepler Cheuvreux
08/23/21 DNB Markets
Maersk Drilling upgraded to Buy from Hold at DNB Markets
Hot Stocks
FinVolution Group sees FY21 transaction volume RMB 130B-RMB 135B » 05:27
10/20/21
10/20
05:27
10/20/21
05:27
FINV

FinVolution Group

$5.95 /

+0.125 (+2.15%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FINV FinVolution Group
$5.95 /

+0.125 (+2.15%)

FINV FinVolution Group
$5.95 /

+0.125 (+2.15%)

09/21/21
Fly Intel: Top five analyst initiations
09/21/21 China Renaissance
FinVolution initiated with Buy, $9.20 target at China Renaissance
09/21/21 China Renaissance
FinVolution Group initiated with a Buy at China Renaissance
08/24/21 Citi
FinVolution Group downgraded to Neutral from Buy at Citi
FINV FinVolution Group
$5.95 /

+0.125 (+2.15%)

Upgrade
New Work upgraded to Buy from Hold at Pareto » 05:25
10/20/21
10/20
05:25
10/20/21
05:25
XINXF

New Work

$300.94 /

+ (+0.00%)

Pareto analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Entra downgraded to Hold from Buy at DNB Markets » 05:24
10/20/21
10/20
05:24
10/20/21
05:24
ENTOF

Entra

$22.10 /

+ (+0.00%)

DNB Markets analyst Simen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENTOF Entra
$22.10 /

+ (+0.00%)

10/13/21 DNB Markets
Entra upgraded to Buy from Hold at DNB Markets
02/09/21 Barclays
Entra downgraded to Equal Weight from Overweight at Barclays
01/13/21 Kepler Cheuvreux
Entra downgraded to Hold from Buy at Kepler Cheuvreux
10/22/20 Barclays
Entra upgraded to Overweight from Underweight at Barclays
Earnings
ASML reports Q3 EPS EUR 4.27 vs. EUR 2.52 last year » 05:24
10/20/21
10/20
05:24
10/20/21
05:24
ASML

ASML

$800.81 /

+12.73 (+1.62%)

Reports Q3 revenue EUR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASML ASML
$800.81 /

+12.73 (+1.62%)

ASML ASML
$800.81 /

+12.73 (+1.62%)

10/14/21 Piper Sandler
Piper Sandler starts ASML at Overweight amid 'powerful tailwinds'
10/14/21 Piper Sandler
ASML initiated with an Overweight at Piper Sandler
09/28/21 New Street
ASML downgraded to Neutral from Buy at New Street
09/24/21 Morgan Stanley
ASML price target raised to EUR 800 from EUR 720 at Morgan Stanley
ASML ASML
$800.81 /

+12.73 (+1.62%)

ASML ASML
$800.81 /

+12.73 (+1.62%)

ASML ASML
$800.81 /

+12.73 (+1.62%)

ASML ASML
$800.81 /

+12.73 (+1.62%)

Upgrade
Norway Royal Salmon upgraded to Buy from Hold at DNB Markets » 05:24
10/20/21
10/20
05:24
10/20/21
05:24
NRYYF

Norway Royal Salmon

$24.25 /

+ (+0.00%)

DNB Markets analyst Stein…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRYYF Norway Royal Salmon
$24.25 /

+ (+0.00%)

05:23 Today Kepler Cheuvreux
Norway Royal Salmon upgraded to Buy from Hold at Kepler Cheuvreux
08/24/21 DNB Markets
Norway Royal Salmon downgraded to Hold from Buy at DNB Markets
02/02/21 Fearnley
Norway Royal Salmon upgraded to Buy from Hold at Fearnley
01/18/21 Danske Bank
Norway Royal Salmon upgraded to Buy from Hold at Danske Bank
Upgrade
Norway Royal Salmon upgraded to Buy from Hold at Kepler Cheuvreux » 05:23
10/20/21
10/20
05:23
10/20/21
05:23
NRYYF

Norway Royal Salmon

$24.25 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NRYYF Norway Royal Salmon
$24.25 /

+ (+0.00%)

08/24/21 DNB Markets
Norway Royal Salmon downgraded to Hold from Buy at DNB Markets
02/02/21 Fearnley
Norway Royal Salmon upgraded to Buy from Hold at Fearnley
01/18/21 Danske Bank
Norway Royal Salmon upgraded to Buy from Hold at Danske Bank
Upgrade
Bakkafrost upgraded to Buy from Hold at Kepler Cheuvreux » 05:22
10/20/21
10/20
05:22
10/20/21
05:22
BKFKF

Bakkafrost

$85.78 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKFKF Bakkafrost
$85.78 /

+ (+0.00%)

04/13/21 Pareto
Bakkafrost upgraded to Hold from Sell at Pareto
11/11/20 Danske Bank
Bakkafrost downgraded to Hold from Buy at Danske Bank
Upgrade
Salmones Camanchaca upgraded to Buy from Hold at Kepler Cheuvreux » 05:22
10/20/21
10/20
05:22
10/20/21
05:22
SLMCF

Salmones Camanchaca

$5.50 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Rocket Pharmaceuticals announces interim data from RP-L201 trial at ESGCT » 05:19
10/20/21
10/20
05:19
10/20/21
05:19
RCKT

Rocket Pharmaceuticals

$28.06 /

+0.49 (+1.78%)

Rocket Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$28.06 /

+0.49 (+1.78%)

RCKT Rocket Pharmaceuticals
$28.06 /

+0.49 (+1.78%)

10/19/21 Cowen
Rocket Pharmaceuticals assumed with an Outperform at Cowen
04/01/21 SVB Leerink
Rocket Pharmaceuticals price target raised to $66 from $61 at SVB Leerink
03/22/21 William Blair
Rocket data shows durable impact for PKD, says William Blair
03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
RCKT Rocket Pharmaceuticals
$28.06 /

+0.49 (+1.78%)

  • 10
    Dec
RCKT Rocket Pharmaceuticals
$28.06 /

+0.49 (+1.78%)

Hot Stocks
Alibaba kicks off 11.11 Global Shopping Festival » 05:15
10/20/21
10/20
05:15
10/20/21
05:15
BABA

Alibaba

$177.02 /

+10.22 (+6.13%)

Alibaba officially kicked…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BABA Alibaba
$177.02 /

+10.22 (+6.13%)

BABA Alibaba
$177.02 /

+10.22 (+6.13%)

10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 KeyBanc
Alibaba price target lowered to $200 from $250 at KeyBanc
10/01/21 Raymond James
Alibaba downgraded to Outperform from Strong Buy at Raymond James
10/01/21 Raymond James
Alibaba downgraded to Outperform from Strong Buy at Raymond James
BABA Alibaba
$177.02 /

+10.22 (+6.13%)

BABA Alibaba
$177.02 /

+10.22 (+6.13%)

BABA Alibaba
$177.02 /

+10.22 (+6.13%)

BABA Alibaba
$177.02 /

+10.22 (+6.13%)

General news
FX Action: The yen posted fresh trend lows » 05:15
10/20/21
10/20
05:15
10/20/21
05:15
$ECON

Economic Data

/

+

FX Action: The yen posted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Triumph Group, Air France-KLM finalize formation of xCelle Americas JV » 05:12
10/20/21
10/20
05:12
10/20/21
05:12
TGI

Triumph Group

$19.77 /

-0.11 (-0.55%)

, AFLYY

Air France-KLM

$4.70 /

-0.155 (-3.20%)

Triumph Group (TGI) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGI Triumph Group
$19.77 /

-0.11 (-0.55%)

AFLYY Air France-KLM
$4.70 /

-0.155 (-3.20%)

TGI Triumph Group
$19.77 /

-0.11 (-0.55%)

08/06/21 UBS
Triumph Group upgraded to Buy from Neutral at UBS
08/05/21 Baird
Triumph Group designated a bullish Fresh Pick at Baird
06/18/21 Truist
Triumph Group price target raised to $30 from $21 at Truist
05/21/21 Canaccord
Triumph Group price target raised to $15 from $13 at Canaccord
AFLYY Air France-KLM
$4.70 /

-0.155 (-3.20%)

10/13/21 Barclays
Air France-KLM price target lowered to EUR 4.40 from EUR 5.50 at Barclays
08/03/21 UBS
Air France-KLM price target raised to EUR 4.60 from EUR 4.35 at UBS
08/02/21 Barclays
Air France-KLM price target raised to EUR 5.50 from EUR 5.20 at Barclays
05/10/21 Berenberg
Air France-KLM price target raised to EUR 3.60 from EUR 3 at Berenberg
TGI Triumph Group
$19.77 /

-0.11 (-0.55%)

TGI Triumph Group
$19.77 /

-0.11 (-0.55%)

Hot Stocks
Novavax sinks 15% following Politico report of vaccine production issues  05:11
10/20/21
10/20
05:11
10/20/21
05:11
NVAX

Novavax

$160.50 /

-5.8 (-3.49%)

 
ShowHide Related Items >><<
NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

Periodicals
Novavax running into production problems with Covid vaccine, Politico reports » 05:11
10/20/21
10/20
05:11
10/20/21
05:11
NVAX

Novavax

$160.50 /

-5.8 (-3.49%)

Novavax (NVAX) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

NVAX Novavax
$160.50 /

-5.8 (-3.49%)

Earnings
Lithia & Driveway reports Q3 adjusted EPS $11.21, consensus $9.28 » 05:09
10/20/21
10/20
05:09
10/20/21
05:09
LAD

Lithia & Driveway

$338.93 /

+0.745 (+0.22%)

Reports Q3 revenue $6.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAD Lithia & Driveway
$338.93 /

+0.745 (+0.22%)

LAD Lithia & Driveway
$338.93 /

+0.745 (+0.22%)

07/22/21 Craig-Hallum
Lithia Motors price target raised to $520 from $500 at Craig-Hallum
07/16/21 BofA
Lithia Motors price target raised to $467 from $460 at BofA
05/21/21
Fly Intel: Top five analyst upgrades
05/21/21 BofA
Lithia Motors upgraded to Buy at BofA on M&A growth potential
LAD Lithia & Driveway
$338.93 /

+0.745 (+0.22%)

  • 20
    May
LAD Lithia & Driveway
$338.93 /

+0.745 (+0.22%)

Recommendations
Piper Sandler remains constructive on Tactile Systems after recent selloff » 05:04
10/20/21
10/20
05:04
10/20/21
05:04
TCMD

Tactile Systems

$36.11 /

+2 (+5.86%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCMD Tactile Systems
$36.11 /

+2 (+5.86%)

TCMD Tactile Systems
$36.11 /

+2 (+5.86%)

07/07/21 Piper Sandler
Tactile Systems qui tam lawsuit timeline extended, says Piper Sandler
07/06/21 Piper Sandler
Tactile Systems has 'long runway for growth,' says Piper Sandler
03/30/21 Piper Sandler
Tactile Systems granted partial favorable judgment, says Piper Sandler
02/24/21 Piper Sandler
Tactile Systems valuation attractive despite guidance, says Piper Sandler
TCMD Tactile Systems
$36.11 /

+2 (+5.86%)

Recommendations
Microsoft price target raised to $375 from $345 at Jefferies » 05:01
10/20/21
10/20
05:01
10/20/21
05:01
MSFT

Microsoft

$308.30 /

+0.84 (+0.27%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$308.30 /

+0.84 (+0.27%)

MSFT Microsoft
$308.30 /

+0.84 (+0.27%)

10/18/21 Morgan Stanley
Morgan Stanley says Cloud, Hybrid solutions should power 'strong' Microsoft Q1
10/06/21 Morgan Stanley
CIO survey shows Microsoft 'further solidifying leadership,' says Morgan Stanley
09/24/21 Oppenheimer
Opco downgrades Cloudflare amid competition from Amazon, Microsoft
09/24/21 Piper Sandler
Salesforce upgraded to Overweight from Neutral at Piper Sandler
MSFT Microsoft
$308.30 /

+0.84 (+0.27%)

MSFT Microsoft
$308.30 /

+0.84 (+0.27%)

MSFT Microsoft
$308.30 /

+0.84 (+0.27%)

MSFT Microsoft
$308.30 /

+0.84 (+0.27%)

Recommendations
Intuitive Surgical price target raised to $330 from $323 at Piper Sandler » 04:59
10/20/21
10/20
04:59
10/20/21
04:59
ISRG

Intuitive Surgical

$336.63 /

+4.45 (+1.34%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

10/01/21 Citi
Intuitive Surgical downgraded to Neutral from Buy at Citi
09/10/21 Stifel
Intuitive Surgical CFO commentary suggests negative revenue impact, says Stifel
07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
07/21/21 SVB Leerink
Intuitive Surgical price target raised to $975 from $930 at SVB Leerink
ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

Recommendations
Netflix Q4 content slate 'still looks compelling,' says Piper Sandler » 04:58
10/20/21
10/20
04:58
10/20/21
04:58
NFLX

Netflix

$639.47 /

+1.62 (+0.25%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

04:51 Today Pivotal Research
Netflix price target raised to $750 from $700 at Pivotal Research
10/19/21 Truist
Netflix's Q3 results 'very solid', says Truist
10/18/21 Loop Capital
Netflix price target raised to $700 from $650 at Loop Capital
10/18/21 UBS
Netflix price target raised to $720 from $620 at UBS
NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

NFLX Netflix
$639.47 /

+1.62 (+0.25%)

Initiation
Jasper Therapeutics initiated with an Outperform at BMO Capital » 04:55
10/20/21
10/20
04:55
10/20/21
04:55
JSPR

Jasper Therapeutics

$13.40 /

+0.04 (+0.30%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JSPR Jasper Therapeutics
$13.40 /

+0.04 (+0.30%)

JSPR Jasper Therapeutics
$13.40 /

+0.04 (+0.30%)

10/12/21 Oppenheimer
Oppenheimer starts 'emerging leader' Jasper Therapeutics with Outperform
10/12/21 Oppenheimer
Jasper Therapeutics initiated with an Outperform at Oppenheimer
JSPR Jasper Therapeutics
$13.40 /

+0.04 (+0.30%)

Conference/Events
NextCure management to meet virtually with BTIG » 04:55
10/20/21
10/20
04:55
10/20/21
04:55
NXTC

NextCure

$8.58 /

+0.015 (+0.18%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$8.58 /

+0.015 (+0.18%)

NXTC NextCure
$8.58 /

+0.015 (+0.18%)

08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/04/21 Piper Sandler
NextCure price target lowered to $26 from $32 at Piper Sandler
NXTC NextCure
$8.58 /

+0.015 (+0.18%)

Conference/Events
IDEX Biometrics participates in a conference call with Northland » 04:55
10/20/21
10/20
04:55
10/20/21
04:55
IDBA

IDEX Biometrics

$21.10 /

+ (+0.00%)

Analyst Richard holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IDBA IDEX Biometrics
$21.10 /

+ (+0.00%)

10/13/21 Northland
IDEX Biometrics initiated with an Outperform at Northland
Conference/Events
JMP Securities biotechnology analysts to hold analyst/industry conference call » 04:55
10/20/21
10/20
04:55
10/20/21
04:55
ENTA

Enanta

$69.79 /

+1.02 (+1.48%)

, ABUS

Arbutus Biopharma

$4.15 /

+0.005 (+0.12%)

, VACC

Vaccitech

$14.45 /

-0.15 (-1.03%)

, VIR

Vir Biotechnology

$40.30 /

+1.58 (+4.08%)

Biotechnology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$69.79 /

+1.02 (+1.48%)

ABUS Arbutus Biopharma
$4.15 /

+0.005 (+0.12%)

VACC Vaccitech
$14.45 /

-0.15 (-1.03%)

VIR Vir Biotechnology
$40.30 /

+1.58 (+4.08%)

ENTA Enanta
$69.79 /

+1.02 (+1.48%)

10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/06/21 Jefferies
Enanta initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Enanta out-licensing news surprising but smart, says Piper Sandler
09/09/21 SVB Leerink
SVB Leerink waiting for outlook clarity, starts Enanta with a Market Perform
ABUS Arbutus Biopharma
$4.15 /

+0.005 (+0.12%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley Securities
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
VACC Vaccitech
$14.45 /

-0.15 (-1.03%)

05/25/21 William Blair
Vaccitech initiated with an Outperform at William Blair
05/25/21 Morgan Stanley
Vaccitech initiated with an Overweight at Morgan Stanley
05/25/21 Jefferies
Vaccitech initiated with a Buy at Jefferies
05/24/21 H.C. Wainwright
Vaccitech initiated with a Buy at H.C. Wainwright
VIR Vir Biotechnology
$40.30 /

+1.58 (+4.08%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Goldman Sachs
Vir Biotechnology downgraded to Neutral from Buy at Goldman Sachs
06/03/21 Baird
Vir Biotechnology assumed with a Neutral at Baird
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
ENTA Enanta
$69.79 /

+1.02 (+1.48%)

ABUS Arbutus Biopharma
$4.15 /

+0.005 (+0.12%)

VACC Vaccitech
$14.45 /

-0.15 (-1.03%)

VIR Vir Biotechnology
$40.30 /

+1.58 (+4.08%)

  • 30
    Apr
ABUS Arbutus Biopharma
$4.15 /

+0.005 (+0.12%)

VACC Vaccitech
$14.45 /

-0.15 (-1.03%)

VIR Vir Biotechnology
$40.30 /

+1.58 (+4.08%)

ABUS Arbutus Biopharma
$4.15 /

+0.005 (+0.12%)

Conference/Events
Intra-Cellular to hold a virtual investor event » 04:55
10/20/21
10/20
04:55
10/20/21
04:55
ITCI

Intra-Cellular

$41.87 /

+0.2 (+0.48%)

Virtual Event to feature…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITCI Intra-Cellular
$41.87 /

+0.2 (+0.48%)

ITCI Intra-Cellular
$41.87 /

+0.2 (+0.48%)

10/19/21 RBC Capital
Intra-Cellular price target raised to $48 from $44 at RBC Capital
09/22/21 Needham
Intra-Cellular initiated with a Buy at Needham
09/20/21 Jefferies
Intra-Cellular price target raised to $70 from $55 at Jefferies
12/29/20 Cantor Fitzgerald
Intra-Cellular price target raised to $54 from $53 at Cantor Fitzgerald
ITCI Intra-Cellular
$41.87 /

+0.2 (+0.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.